Posters

Dr Gabriela Nass Kovacs
Genedata AG
1Automating High-throughput RT-qPCR Analysis for RNA Drug Discovery
Miss Chloe Wilkinson
University of Leeds
2Identification of small molecule modulators of the Insulin Receptor/Insulin-like Growth Factor-1 Receptor hybrid dimer as a future treatment for Type-II diabetes
Dr Simon Erridge
Imperial College London
3Cannflavins – From Plant to Patient: A Scoping Review
Miss Wing Yee Lai
University of East Anglia
4Investigating the involvement of protein kinase D (PKD) on chemokine-induced responses in human breast cancer cells along the CCL3-CCR5 axis
Dr Frederique Tholozan
Magnitude Biosciences
5C. elegans Automated Imaging Platform: De-risking in vitro drug candidates ahead of rodent studies with a non-mammalian model for ageing, neurodegeneration and the microbiome.
Miss Bairu Zhang
AstraZeneca
6Classifying and evaluating tumour responses in preclinical in-vivo models
Dr Johannes Reynisson
School of Pharmacy, Keele University
7Targeting Mtb isocitrate lyase for the treatment of tuberculosis
Miss Benedetta Spadaro
University of Cambridge
8Covid-19: Changing the paradigm of vaccine development
Dr Shushant Jain
Charles River
9Screening in iPSC derived neurons for modifiers of Alzheimer’s related phenotypes
Dr Shushant Jain
Charles River
10In vitro cell based cytotoxicity and T cell activation assays to assess safety and efficacy of engineered T cell therapies
Dr Shushant Jain
Charles River
11Validation of the interaction between a candidate compound and the intended drug target by a phenotypic rescue approach
Miss Abbie Wishart
REPROCELL
12Application of Pharmacogenomics and Bioinformatics to Exemplify the Utility of Human ex vivo Organoculture Models in the Field of Precision Medicine
Mr Ben Flude
Swansea University
13Computer-aided identification of potential broad-spectrum agents for highly-pathogenic human coronaviruses
Pam Williams
Charles River
14Rapid antibody discovery on hard targets combined with fine-grained engineering and optimization | Charles River
Ms Matilde Ortiz González
University of Almeria and GENYO
15A New new member of Curvicollide family kills African trypanosomes by inhibiting transcription
Dr Frank Staubli
Nebion AG
16Curation and integration of single-cell RNA-Seq data for cross-study analysis and interpretation
Dr Lisa Hale
LifeArc
17Fragment-Based Target Screening to Prioritise Novel Antimicrobial Targets
Dr Eugenia Yiannakopoulou
University of West Attica
18Green tea catechins and antiviral effect : a possible preventive strategy against COVID-19?
Dr Eugenia Yiannakopoulou
University of West Attica
19Targeting cellular redox regulation by aspirin and salicylates: a possible therapeutic approach against COVID-19?
Miss Paige Mitchell
Swansea University
20Selective inhibition of serine proteases: Novel therapeutics to modulate coagulation and inflammatory processes.
Dr Hazel Weir
Peak Proteins Ltd
21Measuring coronavirus Spike:ACE2 binding affinity and kinetics using the Biacore 8K
Mr Gwent Paylor
Intelligent OMICS Ltd
22Biomarker and Druggable Target Discovery via Systematic Deep Mining and Pathway Reconstruction in Lung Cancer
Mrs Sonia Houghton
Cryoniss Ltd.
23Supporting the diligent researcher in their quest to generate high quality data
Dr Christoph Sachse
NMI TT Pharmaservices
24Beyond Genomics in Precision Oncology: A Multiplex Pathway Activity Profiling Platform for Tumor and Organoid Samples
Mrs Joanne Walter
Leniobio
25ALiCE®: Fast and scalable solutions to accelerate research
Dr Lauri Paasonen
UPM-Kymmene Corporation
26Automated Three-Dimensional Cell-Based Assays in Nanofibrillar Cellulose Hydrogels
Mr Miles rackliff
Curiox Biosystems Limited
27Replacing the centrifuge to increase T-cell recovery and generate consistent data: The Laminar Wash™ approach
Dr Jose A García-Salcedo
FIBAO
28TARBRAINFEC: Nanosystems conjugated with antobody fragments to target/treat brain infections
Dr Sian Humphreys
Censo Biotechnologies
29Microglia from human iPSC lines carrying Alzheimer’s-associated mutations have a disease-relevant phenotype
Dr Marie Fisher
Cellomatics BioSciences Ltd
30Adoption of functional in vitro assays in support of Immuno-Oncology drug discovery
Mr Nirmal Perera
LGC
31Feasibility of manufacturing-scale bioproduction of novel next- generation 3D organoid cancer models in support of the Human Cancer Models Initiative
Dr Mithila Vaidya
LGC-ATCC
32CRISPR/cas9-mediated Generation of an EMT Reporter Cell Line for Metastatic Breast Cancer Drug Discovery and Development
MSc Kristina Kremer
Miltenyi Biotec
33Fast and efficient T cell isolation without density gradient centrifugation for CAR T cell engineering
Ms Frida Nyberg
Uppsala University
34Sorafenib kills quiescent cancer cells through mitochondrial inhibition
Mrs Gabriela Sanchez
LGC-ATCC
35Luciferase-expressing Monocyte Reporter Cell Lines as a Predictive Human Cell-Based Model for In Vitro Immune Activation Studies
Prof anne dickinson
Alcyomics Ltd
36Drug Discovery and Detecting Immunotoxicity In Vitro- Clinically Relevant Studies in the COVID 19 Era
MSc Kristina Kremer
Miltenyi Biotec
37Isolation of functional cells straight from buffy coat, LRSC, and Leukopak®
Dr Tony Oosterveen
bit.bio
38Optimized reprogramming of human iPSCs to generate distinct neuronal subtypes
Ms Nikita Patel
QMUL
39Inhibition of the effects of macrophage migration inhibitory factor reduces organ injury and dysfunction in a rat model of severe haemorrhage
Miss Diane Smith
AstraZeneca
40The use of Cell Painting to generate morphological profiles
Dr Clare Box
Gifford Bioscience
41SPR Evaluation of Potential Anti-COVID-19 Therapies
Dr Christopher Browne
AstraZeneca
42Multi-omic Profiling of Lung and Breast Cancer Patients
Dr Sebastian Schloer
University of Münster - Center for Molecular Biology of Inflammation
43Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetineA New Poster Abstract
Dr Philip Nevin
AstraZeneca
44Multiplexed LC-MS assay enables accelerated DMTA cycle
Dr sarantis chlamydas
Active Motif
45Epigenetic profiling and drug discovery
Miss Eleanor Godsman
University of Bath
46Non-PROTAC small molecule degraders against ProteinX
Dr Will Bernard
bit.bio
47A novel human skeletal muscle in vitro model using opti-ox mediated cellular reprogramming of induced pluripotent stem cells
Mr. Takeomi Inoue
Carna Biosciences, Inc.
48Kinetic Monitoring of Compound Dissociation from Wild-type and Mutant Kinases in Living Cells with NanoBRET™
Mr. Takeomi Inoue
Carna Biosciences, Inc.
49Kinetic Monitoring of Compound Dissociation from Wild-type and Mutant Kinases in Living Cells with NanoBRET™
Dr George Buckley
Chempartner Europe ApS
50Parallel Fragment Based Drug Discovery Approaches Targeting Nicotinamide phospho-ribosyltransferase (NAMPT)
Dr Eugenia Yiannakopoulou
University of West Attica
51DICLOFENAC REPURPOSING IN ONCOLOGY
Dr Eugenia Yiannakopoulou
University of West Attica
52Modulation of glutathione levels : a possible therapeutic strategy against COVID-19? A New Poster Abstract
Dr Louise Affleck
PerkinElmer | Cisbio
53NOVEL STING PLATFORM FOR NEW COMPOUNDS DISCOVERY
Dr Leanne Wickens
Promega UK Ltd
54Lumit™ Immunoassays: Bioluminescent, Sensitive, and Homogeneous Analyte Detection Using Labelled Antibodies
Ms Colleen Umali
STEMCELL Technologies
55High-Throughput-Compatible Differentiation of Human Pluripotent Stem Cell Lines to Kidney Organoids for Nephrotoxic Drug Screening
Ms Kimmely da Silva
Luminex
5616-color Immunophenotyping of major lymphocyte and myeloid subsets in human PBMCs and whole blood using the CellStreamTM Flow Cytometert
Ms Larissa Heid
Twist Bioscience
57A High-Throughput Platform to Develop Highly Potent and Functional Antibodies against G-protein Coupled Receptors
Eventflo Home
copyright ELRIG, eventflo.co.uk, Labhoo Ltd 2003-2021